A Guide to Due Diligence in Life Science TransactionsDrug and Market Development PublishingSeptember 1, 2002 75 Pages - SKU: DSMD827191 |
Additional Information
This is the only Guide specifically tailored to provide a thorough introduction and overview of the due diligence process for life science ventures.
In the life science industry, buyers and sellers can take several forms. A seller can be a company seeking a merger or acquisition, divesting a product line, licensing a technology, promoting an IPO, or an entrepreneur seeking venture investment. Buyers are the groups looking to acquire, invest, or otherwise purchase from the seller. In any given business transaction the seller will seek to achieve the highest price for their goods, and as a result has an incentive to "polish" any blemishes that would reduce the value for their goods or preclude the transaction from occurring. It is the responsibility of the buyer to uncover these blemishes, and determine how that affects the deal. Due diligence is the response to the cliché "Let the Buyer Beware."
D&MD's Guide to Due Diligence provides an essential introduction to due diligence for readers, including a summary of key investigation areas and critical questions to ask, as well as checklists readily employable in day-to-day business operations. Most importantly, this Guide focuses on the life sciences, and unique business issues within this industry that are not covered in any other comparable publication.
More Global Regulation & Policy Reports
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition by
Kalorama Information
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, ...
Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging: Focus on Europe by
BCC Research
REPORT HIGHLIGHTS
The global pharmaceutical contract manufacturing and contract research organizations revenue reached at $196.5 billion in 2010, it will further grow to $217.9 billion ...
Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets by
BCC Research
The global pharmaceutical contract manufacturing and contract research organizations revenue reached at $196.5 billion in 2010, it will further grow to $217.9 billion in 2011 ...
The World Pharmaceutical Markets Fact Book 2011 by
Espicom Healthcare Intelligence
The indispensable source of thousands of facts, figures and statistics for 66 pharmaceutical markets worldwide!
In today's challenging market environment the need to understand ...
Global Markets for Orphan Drugs by
BCC Research
THIS REPORT CONTAINS
An overview of orphan drug criteria, the history of the Orphan Drug Act and its influence and advantages inherent in ...
See all reports like this >>
Related Markets
Regulation & Policy Reports
- Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
- Orphan Disease Therapeutics Market to 2018 - Improved Understanding of Rare Diseases' Heterogeneity and Novel New Clinical Trial Designs to Foster Innovation
- Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules
- Pricing and Reimbursement in Generics - European Austerity Measures and Healthcare Cost Containment Puts Innovation-Driven Pharma Companies under Pressure
- Pricing and Reimbursement in Russia - Big Pharma Take Advantage of Reimbursement for Costly Drugs Through the DLO’s Seven Nosologies Program

